scholarly journals A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer

Cancer ◽  
2009 ◽  
Vol 115 (8) ◽  
pp. 1713-1722 ◽  
Author(s):  
Edward S. Kim ◽  
Ann M. Mauer ◽  
William N. William ◽  
Hai T. Tran ◽  
Diane Liu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cell Lung Cancer ◽  
Nonsmall Cell Lung Cancer ◽  
Phase 2 ◽  
Phase 2 Study

scholarly journals A front-line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung cancer

Cancer ◽  
2010 ◽  
Vol 116 (24) ◽  
pp. 5686-5693 ◽  
Author(s):  
Grace K. Dy ◽  
Shauna L. Hillman ◽  
Kendrith M. Rowland ◽  
Julian R. Molina ◽  
Preston D. Steen ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cell Lung Cancer ◽  
Nonsmall Cell Lung Cancer ◽  
Window Of Opportunity ◽  
Phase 2 ◽  
Front Line ◽  
Phase 2 Study

scholarly journals Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer

Cancer ◽  
2010 ◽  
pp. NA-NA
Author(s):  
William N. William ◽  
Merrill S. Kies ◽  
Frank V. Fossella ◽  
Diane D. Liu ◽  
Gregory Gladish ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cell Lung Cancer ◽  
Nonsmall Cell Lung Cancer ◽  
Phase 2 ◽  
Phase 2 Study ◽  
Frontline Treatment

scholarly journals Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer

Cancer ◽  
2011 ◽  
Vol 117 (20) ◽  
pp. 4707-4713 ◽  
Author(s):  
Joe Y. Chang ◽  
Ritsuko Komaki ◽  
Charles Lu ◽  
Hong Y. Wen ◽  
Pamela K. Allen ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cell Lung Cancer ◽  
Proton Therapy ◽  
Nonsmall Cell Lung Cancer ◽  
Concurrent Chemotherapy ◽  
Stage Iii ◽  
High Dose ◽  
Phase 2 ◽  
Unresectable Stage ◽  
Phase 2 Study
Sign in / Sign up

Export Citation Format

Share Document